Navigation Links
Chemo May Boost Survival After Lung Cancer Surgery
Date:3/24/2010

Therapy improves outcome for some patients with operable disease, review finds

WEDNESDAY, March 24 (HealthDay News) -- Chemotherapy improves survival for patients with operable non-small cell lung cancer, say researchers who reviewed nearly 50 studies.

The first meta-analysis of 34 studies involving almost 8,500 patients (and more than 3,300 deaths) showed that survival at five years was 64 percent for patients who had chemotherapy and surgery, and 60 percent for patients who had surgery alone.

The second meta-analysis of 13 studies with 2,660 patients (1,909 deaths) showed that survival at five years was 33 percent for patients who had surgery plus radiotherapy and chemotherapy, and 29 percent for patients who had surgery plus radiotherapy alone.

The report was released online March 23 in advance of publication in an upcoming print issue of The Lancet.

"In both meta-analyses we noted little variation in effect according to the type of chemotherapy, other trial characteristics, or patient subgroup," wrote the British and French researchers.

According to a team led by Sarah Burdett of the Medical Research Council Clinical Trials Unit, London, adding in chemotherapy boosted outcomes whether or not patients got the treatment alongside surgery alone, or surgery plus radiotherapy. They contend that, in patients deemed suitable, "platinum-based chemotherapy should be considered for patients at high risk of recurrence -- i.e., those with stage 1B, 2 or 3 disease."

The finding supports the use of chemotherapy in patients with non-small cell lung cancer who have also undergone tumor-removing surgery, Dr. Gregory P. Kalemkerian, of the University of Michigan, wrote in an accompanying commentary.

"Although the survival benefit seems small, worldwide adoption of adjuvant chemotherapy could save up to 10,000 lives every year," he said.

More information

The U.S. National Cancer Institute has more about non-small cell lung cancer.



-- Robert Preidt



SOURCE: The Lancet, news release, March 23, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Recommended Dental Care for Chemotherapy Patients -- Advice from Steven McConnell, DDS
2. Chemotherapy plus synthetic compound provides potent anti-tumor effect in pancreatic cancers
3. Researchers find new chemotherapy combination shows promise in endometrial cancer
4. BioSphere Medical's HepaSphere Microspheres Safely Deliver Doxorubicin in Liver Cancer Chemoembolization Therapy -- Study Presented at SIR
5. Are New Chemo Treatments Cost-Effective?
6. Older Colon Cancer Patients Less Likely to Get Chemo
7. Study evaluates costs and benefits of new chemotherapy drugs
8. Scientists identify microRNA as possible cause of chemotherapy resistance
9. Roche/Genentech/Chugais Herceptin as an Add-On to Standard Chemotherapy Will Become Decision Resources Clinical Gold Standard in 2013 for the Treatment Of Gastric Cancer
10. New developments in nanotechnology tackle the 2 biggest problems associated with chemotherapy
11. Patients with resectable esophageal adenocarcinoma benefit from neoadjuvant chemoradiotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... , ... January 21, 2017 , ... Caronlab Australia, an ... the January ECRM Trade Show in Hilton Head, SC, where it benefited from outstanding ... the quality of its beauty and wellness products. At this trade show, the company ...
(Date:1/21/2017)... ... January 21, 2017 , ... Seamild, the largest manufacturer of oats ... of its owner and founder. As Oat is recognized globally as one of the ... personally as he believes it is a move to sow the seed of good ...
(Date:1/21/2017)... ... January 21, 2017 , ... Northern ... has recently joined their multi-specialty medical group. The dermatology practice provides general ... , “We’re excited to add this excellent dermatology practice to our group’s medical ...
(Date:1/21/2017)... Austin, Texas (PRWEB) , ... January 21, 2017 ... ... surgeries performed by Austin, Texas Periodontist Dr. Dan Holtzclaw in media for its ... features two surgeries performed by Dr. Holtzclaw in which he utilizes creos™ ...
(Date:1/20/2017)... ... ... Overseer at The House of Yahweh has posted a new publication this week pleading to ... time like no other and society needs to understand the only way to help make ... to sound like an old bible beater because religion has a bad rap these days ...
Breaking Medicine News(10 mins):
(Date:1/21/2017)... DUBLIN , Jan 20, 2017 ... "US Clinical Laboratory Testing Market By Type of Test (Tumor, ... Independent), & By Type of Diseases (Tuberculosis, Influenza, Cancer, HIV/AIDS ... ... an attractive destination for healthcare services, market segments, especially clinical ...
(Date:1/21/2017)... Calif. , Jan. 20, 2017 ARMO ... 1b clinical data on the Company,s lead investigational immuno-oncology ... Symposium, co-sponsored by the American Society of Clinical Oncology ... San Francisco, CA. "AM0010 ... activated CD8 + T cells in the blood ...
(Date:1/21/2017)... NEW YORK , Jan. 20, 2017  Faruqi & ... in KemPharm, Inc. ("KemPharm" or the "Company") (NASDAQ: ... against the Company and certain officers and directors and underwriters ... "IPO") to seek the role of lead plaintiff. ... District Court for Johnson County ...
Breaking Medicine Technology: